Investors / United States / Prospect Venture Partners
Prospect Venture Partners
Venture capital · Menlo Park, CA, United States · North America
Prospect Venture Partners is a life sciences venture capital firm that builds biomedical companies. It has raised more than $1B of capital and supports companies from seed to growth stage.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiomedicalhealthcareventure capital
Your fit with Prospect Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsProspect Venture Partners lists 14 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Foresite Capital, Advent Life Sciences and Aisling Capital.
No funding round on record names Prospect Venture Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Prospect Venture Partners' whole history. Rounds on record name 0 companies; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1286%
- No longer answers00%
- Points to another company214%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Foresite Capital
Compare Prospect Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical Inc. focused on delivering medicines for people living with genetically defined conditions | Healthcare & Biotech | Portfolio page | ||
| AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Emergent BioSolutions develops, manufactures, and supplies medical countermeasures and commercial products for public health threats | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Insmed works to deliver breakthroughs in treating serious diseases | Healthcare & Biotech | Portfolio page | ||
| Jazz Pharmaceuticals is a global biopharmaceutical company | Healthcare & Biotech | Portfolio page | ||
| The company develops life-changing medicines by leveraging insights into human biology. | Healthcare & Biotech | Portfolio page | ||
| NinePoint Medical, Inc. develops and provides the NvisionVLE Imaging System for evaluating human tissue microstructure. | Healthcare & Biotech | Portfolio page | ||
| Novavax develops vaccines to help prevent some of the world's most challenging diseases using its proprietary technology platform. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- prospectventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Prospect Venture Partners' profile as data
Pull Prospect Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/prospectventures.com
# also
GET /v1/firms/prospectventures.com/portfolio
GET /v1/firms/prospectventures.com/coinvestors
GET /v1/firms/prospectventures.com/news